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Ca”-induced degradation of the neuronal inositol(l,4,5)-trisphosphate receptor, a protein which regulates Ca”-release from intracellular stores, 
has been examined. The IP,-receptor, immunopurified from rat cerebellum, appeared to be an excellent substrate for purified Ca’+-activated neutral 
protease (calpain). Incubation of membranes or immunopurified IP,-receptor with Ca” and cerebellar cytosol also resulted in degradation of the 
receptor. Two main fragments with approximate molecular masses of 130 and 95 kDa were generated, both of which appeared to derive from the 
carboxyterminal Ca”-channel-contaming part of the protem. These data suggest that activation of the IP,-receptor, by causing increases in 
intracellular [Ca”], might result in degradation of the N-terminal, IP,-binding part of the receptor. 
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1. INTRODUCTION 
Changes in intracellular [Ca”], which regulate a wide 
variety of cellular functions, are partly regulated by 
changes in the levels of inositol 1,4,5_trisphosphate (IP,) 
[l]. This compound, an intracellular messenger which 
mediates the effects of a number of Ca”-mobilizing 
neurotransmitters, hormones and growth factors, 
achieves its effects by binding to an intracellular IP,- 
receptor protein (IP,-R) [2,3]. 
ylmethane sulfonyl fluoride (PMSF) were purchased from Boehringer 
Mannheim, Na’-deoxycholate (DOC) and Ca2’-activated neutral pro- 
teases (80 kDa) were purchased from Sigma, and protein A-Sepharose 
was purchased from Pharmacia Fine Chemicals. Calpeptin was a 
generous gift from T. Tsujinaka, University of Osaka and dr. N.O. 
Solum, Rikshospitalet. Oslo. The catalytic subunit of CAMP-depend- 
ent protein kinase was a gift from dr. S.O. Dsskeland, University of 
Bergen. BCA Protein Assay Reagents were purchased from Pierce. 
2.2. Preparation of antibodies 
The isoforms of the IP,-receptor, all of which have 
approximate molecular masses of 260 kilodalton (kDa) 
when analysed by SDS-PAGE [4,5], contain both a cy- 
toplasmic IP,-binding domain and a transmembrane 
Ca”-channel domain [6,7]. Binding of IP, to the cyto- 
plasmic receptor domain induces Ca” flux through the 
channel domain and thereby leads to increases in cyto- 
plasmic [Ca”] [8,9]. 
A synthetic 18-amino acid peptide corresponding to the C-terminal 
end of the IP,-receptor [6] was synthetized in the Biotechnology Cen- 
ter, Umversity of Oslo. The peptide was coupled to hemocyanin by 
glutaraldehyde prior to injection, and antibodies were raised in rabbits 
by monthly subcutaneous injection of the conjugated peptide mixed 
with Freund’s adjuvant. 
2.3. Tissue preparation 
The IP,-induced increases in [Ca”] may modulate the 
sensitivity of the IP,-R [lO,l 11. Such modulation might 
be caused by Ca2+-regulated phosphorylationl 
dephosphorylation, or binding of other Ca2’-regulated 
proteins [12,13]. In the present study, we have examined 
whether the neuronal isoform [5,14] of the IP,-receptor, 
particularly enriched in the endoplasmic reticulum of 
cerebellar Purkinje cells [15,16], is subjected to Ca”- 
regulated degradation. 
Rat cerebella were homogenized by sonication on ice in 4 ~01s. of 
a buffer containing 0.25 M sucrose, 20 mM Tns-HCl (pH 7.4) and 2 
mM EDTA. The protease inhibitors PMSF (0.1 mM), leupeptin, pep- 
statm, chymostatm and trypsin inhibitor (all in 10 &ml concentra- 
tion) were added as indicated. The homogenate was fractionated by 
centrifugation at 1 .OOO x g for 10 min to remove the nuclei, followed 
by centrifugation at 100,000 x g for 60 min to pellet membranes and 
microsomes from the cytosol [17]. The membrane pellet was resus- 
pended in PBS or Tris-HCl (pH 7.4), at a protein concentration of 
about 7 mg/ml. The cytosol used as enzyme source was prepared as 
described, without any protease-inhibiting substances and without 
EDTA, but with 1 mM DTT. Protein content was analysed by the 
bicmchonimc acid method [18]. 
2. MATERIALS AND METHODS 
2.1. Materials 
Leupeptin, chymostatin, trypsin inhibitor. pepstatin and phen- 
Correspondence address: A.C. Bstvold, Neurochemical Laboratory, 
University of Oslo, POB 115, Blindern 0317, Oslo, Norway. 
2.4. Immunopreciprtation of the IP,-receptor 
Membrane preparations were extracted with 1% (w/v) deoxycholate 
(DOC) on ice for 30 min, which solubilized 95% of the IP,-R. The 
mixture was centrifuged for 30 min at 27,000 x g to remove denatured 
membrane fragments. The resulting supernatant (approximately 5 mg/ 
ml protein) is referred to as the DOC-extract. 
Protein A-Sepharose beads were washed in TBS-Tween 20 (0.05%) 
and then incubated with anti-IP,-receptor antiserum (> 5 h). Follow- 
ing washing in TBS-Tween 20, the beads were incubated with the 
Published by Elsewer Scrence Publishers B. I/: 229 
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Fig. 1. Characterization of anti-IP,-receptor antibodies. (A) Immunoblots of solubilized membrane protems from rat tissues. Membrane proteins 
from rat cells or tissues were separated by SDS-PAGE, transferred to nitrocellulose, probed with crude rabbit anti-IP,-receptor antiserum diluted 
1.500 and visualized by horseradish peroxidase and diaminobenzidine as described. (a) Astrocytes. (b) GH, cells, (c) Vas deferens, (d) Round 
spermatids, (e) Pachytene spermatocytes, (f) Sertoli cells, (g) Peritubular cells from testis and (h) Cerebellum. (B) Autoradiogram of immunopre- 
cipitated IP,-receptor from DOC-solubilized cerebellum membranes phosphorylated with CAMP- dependent protein kinase. Protein A-Sepharose- 
bound IP,-receptor was mcubated with the catalytic subunit of the kinase and [y-“P]ATP for 5 mm, and the phosphorylation was terminated by 
addition of EDTA (final [EDTA] = 50 mM). SDS-PAGE and autoradiography were performed as described in the text. 
DOC-extract diluted 1:3 with TBS-Tween (final [DOC] = 0.33%, w/v) 
at 4°C overnight. The immunocomplexes were isolated by centrifuga- 
tion, and analysed by SDS-PAGE. 
2.5. Phosphorylation of the IP,-receptor 
This was performed as described [16]. 
2.6. Analysu of Cc”‘-dependent proteolysis 
IP,-receptor, immunopurified on the protem A-Sepharose beads as 
described above, was washed twice in TBS-Tween. The beads, or 
alternatively, a crude membrane fraction, were incubated m buffer (20 
mM Tris-HCI, pH 7 4) in the absence or presence of 1 mM Ca” and 
cytosol or calpain, for the times and temperatures indicated. The 
reactions were terminated either by addition of SDS-containmg buffer 
[19] or, m the case of the protein A-Sepharose beads, addition of 
protease inhibitors followed by washmg in ice cold TBS-Tween before 
resuspension in SDS-buffer and analysis by SDS-PAGE. 
2.7. SDS polyacrylamide electrophorexs 
This was performed in 7.5% polyacrylamide gels in accordance with 
Laemmli [ 191. 
2.8. Immunoblotting 
Proteins, separated by SDS-PAGE, were electrotransferred to nitro- 
cellulose [20]. The transferred proteins were incubated with a 1:500 
dilution of the rabbit antiserum followed either by a horseradish per- 
oxidase-conjugated secondary antiserum. or by ‘~51-labelled protein A. 
The antigen-antibody complexes were visualized either by 0.05% di- 
aminobenzidine, 0.03% NiCl: and 0.03% H,OZ in 50 mM NH,CO,. or 
by autoradiography. 
3. RESULTS 
The neuronal form of IP,-receptor, purified from rat 
cerebellum, is composed of subunits of apparent 260 
kDa mass [2]. When rabbit antibodies were raised 
against a synthetic peptide derived from the extreme 
C-terminal end of the IP,-R [6], a single protein with an 
apparent molecular mass of 260 kDa was recognized in 
different cell types when examined by SDS-PAGE and 
Western immunoblots (Fig. IA). Moreover, the im- 
munoreactive protein was an excellent substrate for 
CAMP-dependent protein kinase in vitro (Fig. lB), it 
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was enriched in microsomal fractions (not shown) and 
it was highly concentrated in the cerebellum (Fig. 1A). 
These are all properties that have been described for the 
neuronal isoform of the IP,-receptor [2,16]. The im- 
munoreactive 260 kDa protein therefore appears to rep- 
resent this form of the IP,-R. 
When a membrane fraction from rat cerebellum was 
incubated with [y-“P]ATP in the presence of the cata- 
lytic subunit of CAMP-dependent protein kinase, the 
260 kDa IP,-receptor was strongly labelled (not shown). 
When this 3’P-labelled fraction was further incubated 
with a crude cytosol fraction from rat cerebellum, addi- 
tion of 1 mM Ca7+ to the reaction mixture led to a rapid 
disappearance of the 260 kDa phosphoprotein (not 
IP,-R - 
130 kDa $9 * 
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Ca2+ - - + - + + + 
cytosol ---++++ 
Leupeptin - + - - - + - 
Calpeptin - - - - - - + 
Fig. 2. Immunoblot of membrane preparations incubated with Cal’, 
cytosol, leupeptin and calpeptin. 200 pg membrane protein was incu- 
bated for 15 min at 30°C as described m the text. 35pg of the proteins 
were separated by 7.5% SDS-PAGE and probed with anti-IP,-recep- 
tor antibodies. The immunocomplexes were visuahzed by “‘I-protein 
A and autoradiography 
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Fig. 3. Immunoblot of immunopurified IP,-receptor incubated in the 
presence or absence of cerebellar cytosol, Ca*+, leupeptin and 50pg/ml 
calpeptin for 15 min at 37°C as indicated. Following incubation, the 
proteins were separated by 7.5% SDS-PAGE and probed with anti- 
IP,-receptor antibodies and “‘I-protein A as described. 
shown). Analysis of the same samples by immunoblot- 
ting indicated that this disappearance was due to a deg- 
radation of the immunoreactive protein, and not to a 
Ca”-regulated dephosphorylation of the IP,-R cata- 
lyzed by e.g. calcineurin (Fig. 2). Ca*‘-induced degrada- 
tion was accompanied by a simultaneous increase in 
two immunoreactive protein bands with apparent mo- 
lecular masses of 130 and 95 kDa (Fig. 2). 
These observations indicated that rat cerebellum con- 
tained Ca”-regulated enzymes capable of degrading the 
IP,-receptor. To examine the mechanisms involved, we 
used antibodies coupled to protein A-Sepharose beads 
to affinity-purify the IP,-receptor from rat cerebellar 
membranes. When such immunocomplexes were incu- 
bated with cerebellar cytosol, addition of 1 mM Ca*’ to 
A 
205 - 
wwmr 
-IP,-R 
116- 
9-?- 
66- 
the reaction mixture induced a rapid degradation of the 
purified IP,-receptor, with a main 130 kDa protein band 
being generated as an immunoreactive product (Fig. 3). 
Addition of 10 ,@ml leupeptin, an inhibitor of thiol- 
proteases, completely prevented the Ca2’-induced deg- 
radation of the IP,-receptor. In contrast, addition of 0.1 
mM PMSF or 10 pg/ml trypsin inhibitor, both of which 
are inhibitors of serine proteases, as well as 10 ,&ml 
pepstatin, an inhibitor of lysosomal proteases, did not 
prevent the Ca2’-induced degradation of the IP,-recep- 
tor (not shown). 
These observations indicated that the IP,-receptor 
might be a substrate for the Ca2+-activated neutral thiol- 
dependent protease calpain, [21-231. This question was 
further examined by in vitro incubations with purified 
components. Addition of the purified 80 kDa calpain 
subunit to the immunopurified IP,-receptor led to a 
rapid and efficient degradation of the receptor 260 kDa 
protein (Fig. 4). Finally, addition of 50 ,uglml calpeptin, 
a specific inhibitor of calpain [24], completely prevented 
the Ca*‘-induced degradation of the IP,-receptor cata- 
lyzed by cerebellar cytosol (Figs. 2, 3). 
4. DISCUSSION 
The present study has shown that the IP,-receptor, an 
intracellular membrane protein responsible for release 
of Ca*+ from intracellular stores in response to a variety 
of extracellular signals [1,3], is a target for Ca”-regu- 
lated proteolysis. Moreover, our results suggest that the 
enzyme responsible for the degradation of the IP,-recep- 
tor belongs to the calpain family. These nonlysosomal 
proteolytic enzymes are active at physiological pH and 
require either millimolar or micromolar [Ca”] for acti- 
vation [21-231. It is known that Ca2’ can induce au- 
tolytic cleavage of calpains, thereby increasing the sensi- 
tivities of these enzymes so that they become responsive 
to physiological [Ca”] fluctuations [23]. Hence, it is 
possible that the levels of Cal+ achieved inside cells, 
either in response to increases in [IP,] or in response to 
opening of plasma membrane Ca”-channels, could in- 
duce degradation of the IP,-sensitive Ca”-channel it- 
self. 
The functional consequences of calpain activation are 
not fully understood. When compared to the predomi- 
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Fig. 4. Effect of purified calpain on IP,-receptor. (A) Immunopurified IP,-receptor was treated with 1 U calpain and 1 mM Ca2+ for 1 min at 37°C 
separated by SDS-PAGE and visualized by Coomassie blue staining. (a) Control, (b) calpain + Ca”. (B) Immunoblot of immunopurified 
IP,-receptor following treatment with 1 U purified calpain at 37°C for the following periods: (a) 0 s, (b) 10 s, (c) 30 s, (d) 1 min, (e) 2 min. The 
reactions were terminated by SDS-containing buffer. IP,-receptor was separated by SDS-PAGE, transferred to nitrocellulose. probed with rabbit 
anti-IP,- receptor antiserum and visualized by horseradish peroxtdase and diaminobenztdine as described. 
231 
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nating lysosomal proteases present in most cells, the 
calpains display a relatively narrow substrate specificity 
[23]. However, a number of proteins related to the me- 
tabolism or functions of cellular Cal+ have been re- 
ported to be calpain substrates. These include both 
membrane proteins involved in Ca”-regulation such as 
Ca”-ATPase and the ryanodine receptor [25-281, and 
enzymes important in Ca2+-regulated signal transduc- 
tion such as protein kinase C and phospholipase C 
[23,29,30]. In most cases, calpain-induced degradation 
of these proteins is believed to terminate their functions. 
However, calpain-catalyzed limited proteolysis of some 
of these substrates. e.g. protein kinase C and the Ca2’- 
ATPase, can generate active forms of these proteins 
[25,29]. The Ca2’-induced degradation of the IP,-recep- 
tor observed in this study generated two fragments of 
130 and 95 kDa. Since these fragments retained im- 
munoreactivity towards a C-terminal-specific antibody, 
they presumably are derived from that part of the recep- 
tor where the Ca2’-channel domain is located. 
It has recently been proposed that increases in cy- 
tosolic Ca2’ may act directly upon the IP,-receptor to 
stimulate Ca”+-release, presumably acting as a positive 
feedback system [31.32]. Whether the Ca”-regulated 
cleavage of the cytosolic domain of the lP,-receptor 
observed in this study could lead to such increased func- 
tional activities of the Ca2+-channel domain of the re- 
ceptor remains to be investigated. 
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